Lisa Imundo
Overview
Explore the profile of Lisa Imundo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
317
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schanberg L, Mulugeta L, Akinlade B, Brunner H, Chen J, Colbert R, et al.
Arthritis Rheumatol
. 2023 Apr;
75(10):1856-1866.
PMID: 37067688
Objective: Stakeholders met to address persistent challenges facing the development of therapeutics for polyarticular juvenile idiopathic arthritis (pJIA), which result in fewer approved therapies for children with pJIA than adults...
2.
Ruperto N, Brunner H, Synoverska O, Ting T, Abud Mendoza C, Spindler A, et al.
Lancet
. 2021 Nov;
398(10315):1984-1996.
PMID: 34767764
Background: Tofacitinib is an oral Janus kinase inhibitor. This trial assessed the efficacy and safety of tofacitinib versus placebo in patients with polyarticular course juvenile idiopathic arthritis (JIA). Methods: This...
3.
Wobma H, Jaramillo D, Imundo L
Front Pediatr
. 2019 Nov;
7:407.
PMID: 31681708
Chronic recurrent multifocal osteomyelitis (CRMO) is an uncommon cause of chronic inflammatory bone pain in children that can be disabling. Often, this diagnosis is considered only after a prolonged workup,...
4.
Heyman M, Weiss P, Boyer D, Fussell J, Imundo L, Aye T, et al.
J Pediatr
. 2018 Dec;
204:4-6.e1.
PMID: 30579474
No abstract available.
5.
Galligan E, Fix L, Levin L, Imundo L, Yamashiro D, Garzon M
Pediatr Dermatol
. 2018 May;
35(4):e235-e236.
PMID: 29766561
Indications for everolimus and other drugs within the mammalian target of rapamycin inhibitor class have recently expanded to include tuberous sclerosis complex. Everolimus is generally well tolerated, but it is...
6.
Bloom J, Lin C, Imundo L, Guthery S, Stepenaskie S, Galambos C, et al.
Pediatr Rheumatol Online J
. 2017 Oct;
15(1):76.
PMID: 29041934
Background: H Syndrome is an autosomal recessive disorder characterized by cutaneous hyperpigmentation, hypertrichosis, and induration with numerous systemic manifestations. The syndrome is caused by mutations in SLC29A3, a gene located...
7.
Bernatsky S, Clarke A, Niaki O, Labrecque J, Schanberg L, Silverman E, et al.
J Rheumatol
. 2017 Aug;
44(10):1484-1486.
PMID: 28765255
Objective: To determine cancer incidence in a large pediatric-onset systemic lupus erythematosus (SLE) population. Methods: Data were examined from 12 pediatric SLE registries in North America. Patients were linked to...
8.
Brunner H, Bennett M, Abulaban K, Klein-Gitelman M, ONeil K, Tucker L, et al.
Arthritis Care Res (Hoboken)
. 2015 Oct;
68(7):1003-11.
PMID: 26473509
Objective: Noninvasive estimation of the degree of inflammation seen on kidney biopsy with lupus nephritis (LN) remains difficult. The objective of this study was to develop a Renal Activity Index...
9.
Mina R, Abulaban K, Klein-Gitelman M, Eberhard B, Ardoin S, Singer N, et al.
Arthritis Care Res (Hoboken)
. 2015 Jul;
68(2):195-202.
PMID: 26213987
Objective: To validate clinical indices of lupus nephritis activity and damage when used in children against the criterion standard of kidney biopsy findings. Methods: In 83 children requiring kidney biopsy,...
10.
Brunner H, Silva C, Reiff A, Higgins G, Imundo L, Williams C, et al.
Arthritis Rheumatol
. 2015 Feb;
67(5):1377-85.
PMID: 25676588
Objective: To determine the dose of triptorelin that is sufficient to maintain complete ovarian suppression in female patients with childhood-onset systemic lupus erythematosus (SLE) who require cyclophosphamide therapy, to determine...